Simone Biles Partners with Arcutis to Boost Awareness of Skin…

Event summary

Arcutis Biotherapeutics partners with Olympic gymnast Simone Biles to launch the 'Skin to Believe In' campaign, raising awareness for seborrheic dermatitis and eczema.
Biles endorses ZORYVE (roflumilast), Arcutis' top-prescribed branded topical therapy for inflammatory skin conditions, highlighting its steroid-free, once-daily application.
ZORYVE foam and cream demonstrated significant efficacy in clinical trials, with 77% of seborrheic dermatitis patients and 31% of eczema patients achieving clear or almost clear skin.
Arcutis aims to empower patients to seek long-term, steroid-free treatment options through the campaign.

The big picture

Arcutis' partnership with Simone Biles underscores the growing trend of celebrity endorsements in healthcare marketing, aiming to destigmatize chronic skin conditions and promote innovative treatments. The campaign aligns with broader industry shifts toward patient-centric care and the demand for non-steroidal, topical therapies. With ZORYVE already the top-prescribed branded therapy for three major inflammatory skin conditions, Arcutis is positioning itself as a leader in immuno-dermatology.

What we're watching

Market Penetration: How Arcutis will leverage Biles' influence to expand ZORYVE's market share in the competitive dermatology space.
Patient Adoption: Whether the campaign will drive more patients to seek steroid-free, long-term treatment options for chronic skin conditions.
Regulatory Dynamics: The pace at which Arcutis can secure additional regulatory approvals for ZORYVE in new indications or age groups.